by thaan@22fillmore.com | Aug 6, 2026
Infinant Health is a clinical-stage company developing INF108, a therapy designed to restore the beneficial bacterial strain B. infantis EVC001 in the infant gut microbiome to prevent necrotizing enterocolitis in preterm infants.
by Carolyn Helms | Sep 19, 2025
Assembly Biosciences is a biotechnology company developing innovative small-molecule therapeutics designed to treat serious viral diseases.
by Carolyn Helms | Jun 6, 2025
Helicore Biopharma is a biotechnology company that is developing a portfolio of first-in-class GIP (glucose-dependent insulinotropic peptide) antagonists for obesity and related conditions.